URNU:F:F-Global X Uranium UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 16.034

Change

-0.04 (-0.27)%

Market Cap

N/A

Volume

180.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.49 (+1.74%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.12 (+0.23%)

USD 114.13B
SXR8:F iShares Core S&P 500 UCITS ETF..

+4.76 (+0.77%)

USD 106.46B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.64 (+1.11%)

USD 100.12B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 63.18B
VUAA:F Vanguard S&P 500 UCITS Acc

N/A

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.83 (+0.75%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+3.40 (+1.39%)

USD 51.11B
XJSE:F Xtrackers II - Japan Governmen..

+0.15 (+1.95%)

USD 43.12B
0ZC:F Zscaler Inc

+2.00 (+1.03%)

USD 37.92B

ETFs Containing URNU:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.99% 84% B 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.99% 84% B 70% C-
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 17.93% 91% A- 78% C+
Dividend Return 17.93% 89% A- 71% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 22.29% 18% F 62% D
Risk Adjusted Return 80.43% 80% B- 85% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.